Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer

Breast cancer (BC) is the most common malignancy in women worldwide. While the main systemic treatment option is anthracycline-containing chemotherapy, chemoresistance continues to be an obstacle to patient survival. Carnitine palmitoyltransferase 1C (CPT1C) has been described as a poor-prognosis ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Muley, Helena, Valencia, Karmele, Casas, Josefina, Moreno, Bea, Botella, Luis, Lecanda, Fernando, Fadó, Rut, Casals, Núria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864098/
https://www.ncbi.nlm.nih.gov/pubmed/36674468
http://dx.doi.org/10.3390/ijms24020946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864098/
https://www.ncbi.nlm.nih.gov/pubmed/36674468
http://dx.doi.org/10.3390/ijms24020946

Ejemplares similares